Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Nasopharyngeal Carcinoma × Sodium Chloride × Clear all

Phase

Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 3 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Leukemia 2 Hodgkin Disease 2 Waldenstrom Macroglobulinemia 1 Tissue Adhesions 1 Thrombocythemia, Essential 1 Sezary Syndrome 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pancreatic Neoplasms 1 Neutropenia 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Myoma 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Mycosis Fungoides 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Mantle-Cell 1

Interventions

Cisplatin 5 toripalimab 4 pembrolizumab 3 Gemcitabine 3 Radiotherapy, Intensity-Modulated 2 Heavy Ion Radiotherapy 2 spartalizumab 1 nedaplatin 1 icotinib 1 fludarabine phosphate 1 fludarabine 1 anlotinib 1 Vorinostat 1 TP protocol 1 Sodium Chloride 1 Quality of Life 1 Paclitaxel 1 Interleukin-2 1 Immunotherapy, Adoptive 1 Gefitinib 1 Cyclophosphamide 1 Cetuximab 1 Celecoxib 1 Bevacizumab 1 Adjuvants, Pharmaceutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01449942 2011-10-10

NPC-DZ

Xiangya Hospital of Central South University

Phase 1/2 Completed

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡